BioSpace News Archive

Drug Development

Novartis and BeiGene Tout Positive Late Data in Head and Neck Cancer

The data collected from the cut-off demonstrates that patients can maintain an average of 9.6 months without disease progression after the initial dosage of the tislelizumab-chemotherapy treatment.

April 18, 2022
·
3 min read
·
Jazmine Colatriano, M.S.
Drug Development

Life Sciences Supply Chain Disruptions Likely to Persist through 2022

To cope, life sciences companies are undertaking a supply chain risk assessment, conducting make-or-buy assessments, investing in supply chain technology and identifying backup suppliers.

April 18, 2022
·
4 min read
·
Gail Dutton
Drug Development

World Hemophilia Day: Exploring the Latest R&D Breakthroughs

In honor of World Hemophilia Day, BioSpace takes a look at some of the facts relating to the disease, and some of the highlights in recent hemophilia research and development.

April 18, 2022
·
3 min read
·
Hayley Shasteen
Policy

Individual Studies Suggest Pfizer’s Paxlovid May Treat COVID-19

There are very few ongoing clinical trials on treatments for Long COVID and there has been what appears to be a successful treatment using Pfizer’s Paxlovid. Read on for more details.

April 18, 2022
·
5 min read
·
Mark Terry
Career Advice

Is a Career in Biotech Right for You?

Thinking about starting a career in biotech? We’ve put together a guide to help you decide where to go within the biotech field and what steps you should take to get there.

April 18, 2022
·
5 min read
·
Kaley Lefevre
King’s College Explores the Potential of mRNA in Treating Heart Attacks

The university’s most recent discovery utilizes messenger RNA (mRNA) technology to combat the physiological effects of heart attacks – with potential for a near reversal of heart muscle damage.

April 18, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Chinese Herbal Supplement Joins List of Disavowed COVID-19 Therapies

The Chinese government has halted the recommendation of Lianhua Qingwen used as a traditional Chinese treatment for mild cases of COVID-19.

April 18, 2022
·
2 min read
·
Alex Keown
BioMidwest

Eli Lilly Faces $165M in Charges over R&D Acquisitions in Latest SEC Exchange

The charges come from several in-process research and development projects acquired outside of a business combination.

April 18, 2022
·
2 min read
·
Hannah Chudleigh
Job Trends

Heat Biologics’ New Biodefense Facility to Create 500 Kansas Jobs

Heat Biologics announced a new development underway in its partnership with Scorpion Biological Services to develop a manufacturing facility in Manhattan, Kansas.

April 18, 2022
·
2 min read
·
Hayley Shasteen
Virtual Science AI Launches Virtual Advisory AI

Virtual Science AI announces the launch of Virtual Advisory AI, a virtual engagement platform designed to deliver the most effortless advisory board engagement experiences and the industry’s first AI-driven analytics following life science advisory board activities

April 18, 2022
·
3 min read